Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Transgender identity and experiences of violence victimization, substance use, suicide risk, and sexual risk behaviors among high school students - 19 states and Large Urban School Districts, 2017.MMWR Morb Mortal Wkly Rep. 2019; 68: 67-71
- Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature.Child Adolesc Ment Health. 2021; 26: 3-14
- Endocrine treatment of gender-Dysphoric/gender-incongruent Persons: An Endocrine Society clinical practice Guideline [published correction appears in J Clin Endocrinol Metab. 2018;103:699] [published correction appears in J Clin Endocrinol Metab. 2018 Jul 1;103(7):2758-2759].J Clin Endocrinol Metab. 2017; 102: 3869-3903
- Standards of care for the health of transsexual, transgender, and gender nonconforming people [7th Version].(Available at:)https://www.wpath.org/publications/socDate: 2012Date accessed: November 25, 2021
- Use of gonadotropin-releasing hormone analogs in children: Update by an international consortium.Horm Res Paediatr. 2019; 91: 357-372
- Efficacy and tolerability of 1- and 3-month leuprorelin acetate depot formulations (Eligard(®)/Depo-Eligard(®)) for advanced prostate cancer in daily practice: A Belgian prospective non-interventional study.Arch Med Sci. 2014; 10: 477-483
- Serum luteinizing hormone rises within minutes after depot leuprolide injection: Implications for monitoring therapy.Pediatrics. 2002; 109: E30
- The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: A single 30-minute post-stimulation LH sample is adequate.J Pediatr Endocrinol Metab. 2008; 21: 1113-1118
- Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: Preliminary results.Clin Endocrinol (Oxf). 2009; 71: 686-690
- A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.J Clin Endocrinol Metab. 2004; 89: 4338-4342
- 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty.J Clin Endocrinol Metab. 2014; 99: 3153-3159
- Insurance coverage of puberty blocker therapies for transgender youth.Pediatrics. 2015; 136: 1029-1031
- A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty.J Pediatr. 2011; 159: 982-987.e1
- Lexicomp. (n.d.). Leuprolide: Drug information. UpToDate.(Available at:)https://www.uptodate.com/contents/leuprolide-drug-informationDate accessed: January 31, 2022
- Endocrinology of transgender medicine.Endocr Rev. 2019; 40: 97-117
Publication stageIn Press Corrected Proof
Conflicts of interest: P.S. has grant funding from Soleno Therapeutics, Inc and has been on the advisory board for Radius Inc.